LONDON — The Ontario government is connecting more people to care by being the first Canadian jurisdiction to publicly fund and administer PLUVICTOTM a new treatment for advanced-stage prostate cancer, which is now covered under the province’s publicly funded drug program. “Our government is giving people access to more treatment options by expanding public access to new medications and treatments,” said …